|
End-of-day quote
Korea S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 4,790.00 KRW | -0.21% |
|
-0.21% | -12.43% |
| 05-13 | BioNote's Net Income Jumps 925% in Q1; Shares Rise 3% | MT |
| 05-13 | Bionote Inc Q1 provisional operating profit 6.3 billion won up 35.2% Y/Y | RE |
| Market Cap | 483B 359M 309M 291M 265M 497M 33.89B 498M 3.43B 1.33B 17.39B 1.35B 1.32B 56.01B | P/E 2024 |
8.69x | P/E 2025 | -6.32x |
|---|---|---|---|---|---|
| Enterprise Value | 147B 109M 94.06M 88.5M 80.84M 151M 10.32B 152M 1.05B 406M 5.3B 410M 402M 17.06B | EV / Sales 2024 |
0.77x | EV / Sales 2025 | 1.84x |
| Free-Float |
12.48% | Yield 2024 |
4.25% | Yield 2025 | - |
| 1 day | -0.21% | ||
| 1 week | -0.21% | ||
| Current month | +0.42% | ||
| 1 month | +0.74% | ||
| 3 months | +2.13% | ||
| 6 months | -12.27% | ||
| Current year | -12.43% |
| 1 week | 4,705 |  | 4,850 |
| 1 month | 4,670 | | 5,080 |
| Current year | 4,050 | | 6,260 |
| 1 year | 4,050 | | 6,320 |
| 3 years | 3,800 | | 6,400 |
| 5 years | 3,800 | | 11,700 |
| 10 years | 3,800 | | 11,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Byung-Ki Cho
CEO | Chief Executive Officer | 58 | 01/08/2020 |
Guk-Myung Lee
DFI | Director of Finance/CFO | 54 | 01/04/2021 |
Hye-Im Cho
SAM | Sales & Marketing | 39 | 26/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Young-Sik Cho
CHM | Chairman | 65 | 01/03/2023 |
Byung-Ki Cho
BRD | Director/Board Member | 58 | 01/08/2020 |
Jung-Ho Kim
BRD | Director/Board Member | 50 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/5/25 A | Free | 10,000,000 | 9.8058% | |||
| 2/5/25 A | Don | Chairman | 10,000,000 | 9.8058% | ||
| 4/14/24 A | Others | 6,729,843 | 6.5991% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | -0.21% | -15.52% | -9.79% | 359M | |
| -2.13% | +7.86% | +20.26% | -81.69% | 2.38B | |
| +3.03% | -40.26% | -51.92% | -60.56% | 1.5B | |
| -0.22% | 0.00% | -47.22% | - | 54.15M | |
| Average | +0.12% | -8.16% | -23.60% | -50.68% | 1.07B | |
| Weighted average by Cap. | -0.14% | -9.72% | -8.86% | -68.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 103B 76.32M 65.67M 61.79M 56.44M 106M 7.21B 106M 730M 283M 3.7B 287M 280M 11.91B | 118B 87.86M 75.6M 71.13M 64.98M 122M 8.3B 122M 841M 326M 4.26B 330M 323M 13.71B |
| Net income | 55.26B 41.03M 35.31M 33.22M 30.35M 56.77M 3.87B 56.93M 393M 152M 1.99B 154M 151M 6.4B | -87.5B -64.97M -55.91M -52.6M -48.05M -89.89M -6.13B -90.13M -622M -241M -3.15B -244M -239M -10.14B |
| Net Debt | -401B -298M -257M -241M -220M -412M -28.15B -414M -2.85B -1.11B -14.44B -1.12B -1.1B -46.52B | -336B -250M -215M -202M -185M -345M -23.57B -346M -2.39B -927M -12.09B -937M -917M -38.95B |
Employees
298
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | ₩4,790.00 | -0.21% | 41,640 |
| 03/09/26 | ₩4,800.00 | +0.73% | 68,588 |
| 02/09/26 | ₩4,765.00 | -0.73% | 32,078 |
| 01/09/26 | ₩4,800.00 | +0.63% | 40,996 |
| 31/08/26 | ₩4,770.00 | -0.62% | 34,275 |
- Stock Market
- Stocks
- A377740 Stock
Select your edition
All financial news and data tailored to specific country editions
